Ascendis Pharma A/S (ASND) - Financial and Strategic SWOT Analysis Review



Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates for treatment. The company’s products are used in the therapeutic areas of diabetes, growth hormone deficiency, endocrinology, and others. It partners with pharmaceutical and biotechnology companies to develop new products. The company has its operations in the US, Germany and Denmark. Ascendis is headquartered in Hellerup, Denmark.

Ascendis Pharma A/S Key Recent Developments

May 19,2020: Ascendis Pharma reports first quarter 2020 financial results
May 11,2020: Ascendis Pharma A/S Will Appoint Jesper H iland as Global Chief Commercial Officer
Apr 16,2020: Ascendis to sell Scitec for a paltry R100m
Apr 01,2020: Ascendis Pharma reports full-year 2019 financial results

This comprehensive SWOT profile of Ascendis Pharma A/S provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ascendis Pharma A/S including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 



Section 1 - About the Company

Ascendis Pharma A/S - Key Information
Ascendis Pharma A/S - Overview
Ascendis Pharma A/S - Key Employees
Ascendis Pharma A/S - Key Employee Biographies
Ascendis Pharma A/S - Key Operational Heads
Ascendis Pharma A/S - Major Products and Services
Ascendis Pharma A/S - History
Ascendis Pharma A/S - Company Statement
Ascendis Pharma A/S - Locations And Subsidiaries
Ascendis Pharma A/S
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Ascendis Pharma A/S - Business Description
Ascendis Pharma A/S - Corporate Strategy
Ascendis Pharma A/S - SWOT Analysis
SWOT Analysis - Overview
Ascendis Pharma A/S - Strengths
Ascendis Pharma A/S - Weaknesses
Ascendis Pharma A/S - Opportunities
Ascendis Pharma A/S - Threats
Ascendis Pharma A/S - Key Competitors

Section 3 - Company Financial Performance Charts

Ascendis Pharma A/S - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



Ascendis Pharma A/S, Key Information
Ascendis Pharma A/S, Key Ratios
Ascendis Pharma A/S, Share Data
Ascendis Pharma A/S, Major Products and Services
Ascendis Pharma A/S, History
Ascendis Pharma A/S, Key Employees
Ascendis Pharma A/S, Key Employee Biographies
Ascendis Pharma A/S, Key Operational Heads
Ascendis Pharma A/S, Other Locations
Ascendis Pharma A/S, Subsidiaries
Ascendis Pharma A/S, Key Competitors
Ascendis Pharma A/S, SWOT Analysis
Ascendis Pharma A/S, Ratios based on current share price
Ascendis Pharma A/S, Annual Ratios
Ascendis Pharma A/S, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



Ascendis Pharma A/S, Performance Chart
Ascendis Pharma A/S, Ratio Charts
 


Ascendis Pharma AS (ASND) - Financial and Strategic SWOT Analysis Review

Ascendis Pharma AS (Ascendis Pharma) is a biopharmaceutical company that focuses on developing drugs for endocrinology and oncology indications. It is investigating TransCon hGH, a long-acting human growth hormone prodrug

USD 300 View Report

Ascendis Pharma AS (ASND) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The companys pipeline products include transcon growth hormone, transcon PTH, transcon CNP, transcon treprostinil, transcon

USD 250 View Report

Ascendis Pharma AS (ASND) - Financial and Strategic SWOT Analysis Review

Ascendis Pharma AS (Ascendis Pharma) is a biopharmaceutical company that focuses on developing drugs for endocrinology and oncology indications. It is investigating TransCon hGH, a long-acting human growth hormone prodrug

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available